SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694187-19-000010
Filing Date
2019-03-01
Accepted
2019-03-01 18:17:43
Documents
2
Period of Report
2019-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155148224874668.html 4  
1 FORM 4 wf-form4_155148224874668.xml 4 5906
2 EXHIBIT 24.1 - POWER OF ATTORNEY powerofattorneymarch2019.htm EX-24 4050
  Complete submission text file 0001694187-19-000010.txt   11383
Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Al-Wakeel Yasir B. (Reporting) CIK: 0001650691 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38551 | Film No.: 19651082

Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Issuer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)